Frontiers Journey of a lifetime The Cancer Center at Salk celebrates 50 years of life-changing discoveries
Special Feature Tony Hunter How an animal virus discovery more than 40 years ago led to one of today’s most successful cancer drugs
Salk’s Cancer Center has become a powerhouse of critical discoveries that have led to treatments and remissions for patients. The Center’s mission is to make current generations the last to see cancer as anything other than a routine diagnosis.
In the News
Tony Hunter—How an animal virus discovery more than 40 years ago led to one of today’s most successful cancer drugs
The story behind how Hunter discovered the first kinase that phosphorylates the amino acid tyrosine. The finding led to the development of Gleevec, a medication that is now routinely used to treat chronic myelogenous leukemia (CML).
Flores had studied the design of the Salk Institute as an architectural engineering student, but never did she imagine that she would be the executive director of the Institute’s Cancer Center years later.
Mondal is a postdoctoral researcher in Assistant Professor Christina Towers’ lab where she studies the mechanisms involved in cancer progression. Her hope is that her projects will someday be translated into therapeutics to help people.
An affinity group network launched at the Salk Institute in 2020 with the founding of two groups: the Black Association at Salk (BAS) and Underrepresented Minorities Actively Supporting Excellence (URMase). The network soon added two more groups: Asian Pacific Islander and Desi at Salk (APIDAS) and the Salk Pride Society (SPS).
“As I reflect on my time as president, I am filled with gratitude for the opportunity to work with such an exceptional group of individuals. The progress we have made together in advancing Salk’s mission and goals is truly gratifying.”